SCHEMBL16092235

SCHEMBL16092235

CC(C)c1c(-c2cccnc2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 7/20 0.53
KDM5B Q9UGL1 2/20 0.42
KDM6B O15054 1/20 0.40
KDM5C P41229 1/20 0.40
KDM5D Q9BY66 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
PHF8 Q9UPP1 1/20 0.40
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
KDM4D Q6B0I6 1/20 0.37
DHODH Q02127 1/20 0.36
PDE10A Q9Y233 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
MDM2 Q00987 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092249 0.89 KDM5A (0.47) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092513 0.87 KDM5A (0.46) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092393 0.86 KDM5A (0.49) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092096 0.86 KDM5A (0.47) KDM5AKDM5BKDM5CKDM4C
SCHEMBL16092276 0.85 KDM5B (0.53) KDM5AKDM5BKDM5CKDM4CKDM4E
SCHEMBL16092243 0.84 KDM5A (0.43) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092293 0.84 KDM5A (0.39) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092493 0.84 KDM5B (0.48) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL17547821 0.83 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D
SCHEMBL16092419 0.83 KDM5A (0.41) KDM5AKDM5BKDM6BKDM5CKDM5D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 US disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885KDM5B 3/4885KDM6B 11/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885KDM5B 3/4885KDM6B 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.